A modeling study predicts a substantial rise in MASLD prevalence and associated liver-related complications in the United ...

In patients with metabolic dysfunction-associated steatotic liver disease, there is increased risk for heart failure with preserved ejection fraction.

A new study published in the journal of Diabetes Research and Clinical Practice showed that metabolic dysfunction may be ...

The global rise in obesity and type 2 diabetes is fueling an epidemic of MASLD and MASH, now recognized as the leading cause ...

The following is a summary of "Potential predictive role of Non-HDL to HDL Cholesterol Ratio (NHHR) in MASLD: focus on obese ...

Dr. Meghraj Ingle reminds nonalcoholic fatty liver disease (NAFLD), which got no noticeable symptoms in its early stages, can ...

Young adulthood obesity is associated with greater odds for MASLD, at-risk MASH, and increased liver stiffness measurement.

Discover how semaglutide aids weight loss in individuals with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD ...

Alcoholic and non-alcoholic fatty liver disease (NAFLD) are well-known risk factors for colorectal cancer (CRC). NAFLD has emerged as a heterogenous ...

Patients with type 1 diabetes comorbid with metabolic dysfunction-associated steatotic liver disease had a low prevalence of advanced liver fibrosis.